The Life Sciences Virtual Investor Forum, co-hosted by B2i Digital, Inc. and Zacks Small-Cap Research, will take place over two days on June 24 and 25, 2026, featuring 22 public companies from across the life sciences spectrum. The event provides investors with direct access to management teams through live presentations, real-time Q&A, and one-on-one meetings, addressing a critical need for efficient capital formation in the sector.
According to the announcement, the forum spans clinical-stage biotechnology, rare-disease and oncology therapeutics, molecular diagnostics, medical devices, veterinary medicine, nutrition science, and AI-powered digital health. Each presenting company has 30 minutes for a live presentation followed by a Q&A session. One-on-one meeting requests can be made through the Axle Access platform, and replays will be available on B2i Digital and OTC Markets YouTube channels.
The lineup for Day One includes Protalix BioTherapeutics, MetaVia Inc., CytoSorbents Corporation, PetVivo Holdings Inc., Jaguar Health, Inc., Reviva Pharmaceuticals Holdings, Inc., and 4DMedical Ltd. Day Two features Prostatype Genomics AB, Abingdon Health plc, Innovotech, Inc., Lakewood-Amedex Biotherapeutics Inc., Nasus Pharma Ltd., Kelyniam Global, Inc., IMUNON, Inc., Promino Nutritional Sciences Inc., Envoy Medical Inc., Coiled Therapeutics plc, Aspire Biopharma Holdings Inc., Rocket Doctor AI Inc., Phio Pharmaceuticals Corp., aTyr Pharma, Inc., and NuFarm Ltd.
David Shapiro, Chief Executive Officer of B2i Digital, emphasized the forum's value: "Life sciences investors want efficient, direct access to management teams developing the therapies and technologies that matter, and pairing that access with independent research from Zacks makes the forum more valuable on both sides." B2i Digital serves as the Official Marketing Partner, amplifying the event across its platform, which reaches a proprietary network of more than 1.7 million retail and institutional market participants. The company has served as marketing partner for over 115 investor conferences.
Zacks Small-Cap Research, a preferred provider in the OTC Markets Group's Research Marketplace, prepares independent company-sponsored research and related content. Its team of life sciences analysts supports the forum as co-host, providing investors with additional insights. The event is part of the Virtual Investor Conferences series, a property of OTC Markets Group Inc., which features public companies from exchanges worldwide including NYSE, Nasdaq, TSX, TSXV, CSE, ASX, LSE, and OTC Markets.
Registration and company profiles are available at the event page. The forum underscores the ongoing importance of investor access to life sciences companies, which often require significant capital to advance therapies and technologies that address unmet medical needs. By consolidating multiple companies into a focused two-day event, the forum aims to streamline investor due diligence and foster meaningful engagement between management teams and potential investors.
